CEO SUMMARY: With the advent of 2013, almost every lab was responding to some type of price cut. Clinical labs are dealing with the sequential, multi-year cuts to the Medicare Part B Lab Test Price Schedule. Anatomic pathology labs are still adjusting to the expiration of the TC Grandfather clause last summer, as well as …
Anticipating Washington’s Next Blows to Lab Testing Read More »
To access this post, you must purchase The Dark Report.